Funding for neurotechnology poses unique challenges and offers substantial opportunities for medical device investors, compared to other fields like cardiovascular or ophthalmology. https://www.lsieuropesummit.com/news/insights-from-lsi-europe-23-building-investing-commercial-success-in-brain-health-the-ethical-implications-of-neuroinnovation